US opens tariff probes on medtech, robotics, and industrial machinery; higher duties on imported PPE, syringes/IV equipment, imaging gear, and machine tools are on the table under Section 232. This shifts advantage toward U.S.-made supply and raises costs for import-reliant players.

Winners — U.S. PPE & IV supply chain

Reason: Tariffs on imported masks, gloves, syringes, IV bags, and infusion pumps could lift pricing power and volumes for domestic manufacturers.

$MMM (3M), $OMI (Owens & Minor), $ICUI (ICU Medical)

Winners — U.S. automation & machine-tool ecosystem

Reason: Duties on imported robotics, stamping/pressing machines, and laser/water-cutting tools could steer capex toward domestic providers and integrators.

$ROK (Rockwell Automation), $DOV (Dover), $PH (Parker-Hannifin)